Product Code: GVR-4-68040-163-3
Pulmonary Stents Market Growth & Trends:
The global pulmonary stents market size is expected to reach USD 306.09 million by 2030, registering a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is a major driving force behind the expansion of the market. According to the Global Initiative for Asthma (GINA), about 200 million people worldwide are affected by COPD, with an estimated 3.2 million deaths annually. Lung cancer, a leading public health concern in the U.S., is witnessing a rise in incidence and mortality rates, further fueling the growth of the market. These stents are employed to treat various respiratory conditions, including lung cancer.
According to projections from the American Cancer Society, it is anticipated that approximately 238,340 new cases of lung cancer were diagnosed in the United States in 2023. Most of these diagnoses are expected to be in individuals aged 65 and above, with a relatively small percentage affecting those under 45. This disease poses a significant public health threat, particularly among older adults, with an average age of diagnosis around 70 years. Notably, lung cancer ranks as the leading cause of cancer-related deaths in the U.S., contributing to one in every five cancer fatalities. Annually, more lives are lost to lung cancer than the combined total of deaths from breast, colon, and prostate cancer.
The pulmonary stents industry is experiencing notable growth due to advancements in new stent technologies, particularly in the areas of 3D-printed self-expanding stents (3DPSS), biodegradable stents (BS), and drug-eluting stents (DES). According to a study published in November 2023 by the National Center for Biotechnology Information (NCBI), these innovations offer several advantages over traditional stents, including improved patient outcomes, reduced complication rates, and enhanced quality of life.
Pulmonary Stents Market Report Highlights:
- North America led the market with a revenue share of 43.69% in 2023. The region's advanced healthcare infrastructure, increasing awareness about respiratory health, and a growing aging population contribute to the market's dominance
- Based on product, the balloon-expandable stents segment dominated the market with a revenue share of 53.40% in 2023. These stents are often preferred when precise placement and controlled expansion are critical
- Based on material, the metal segment dominated the industry with a revenue share of 58.89% in 2023. The growth of Metal is propelled with bare metal, and drug-eluting stents are primarily used for narrowed arteries, most commonly in the heart's coronary arteries
- Based on type, the tracheobronchial stents segment dominated the market with a revenue share of 72.12% in 2023. Tracheobronchial stents play a crucial role in the medical management of conditions such as tracheal or bronchial stenosis, strictures, or obstructions
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Material
- 1.1.3. Type
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Material outlook
- 2.2.3. Type outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Pulmonary Stents Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of respiratory diseases
- 3.2.1.2. Growing geriatric population and healthcare awareness
- 3.2.1.3. Increasing minimally invasive procedures
- 3.2.1.4. Advancements in new stent technology
- 3.2.2. Market restraint analysis
- 3.2.2.1. Availability of Alternative Treatments
- 3.2.2.2. Complications Associated with Stents
- 3.3. Pulmonary Stents Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Pulmonary Stents Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Self-expandable Stents
- 4.1.2. Balloon-expandable Stents
- 4.2. Product Market Share, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Pulmonary Stents Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Self-expandable Stents
- 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Balloon-expandable Stents
- 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Pulmonary Stents Market: Material Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Metal
- 5.1.2. Silicon
- 5.1.3. Hybrid
- 5.2. Material Market Share, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Pulmonary Stents Market by Material Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Metal
- 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Silicon
- 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.3. Hybrid
- 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Pulmonary Stents Market: Type Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Tracheobronchial Stents
- 6.1.2. Laryngeal Stents
- 6.2. Product Market Share, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Pulmonary Stents Market by Type Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Tracheobronchial Stents
- 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
- 6.5.2. Laryngeal Stents
- 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Pulmonary Stents Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8.2. Mexico
- 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Bess medizintechnik GmbH
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Boston Scientific Corporation
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Cook Group
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. E. Benson Hood Laboratories Inc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Efer Endoscopy
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Endo-Flex GmbH
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Merit Medical Systems Inc.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Micro-Tech (Nanjing) Co. Ltd
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Standard Sci Tech Inc.
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Olympus Corporation
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives